Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Lithium was associated with a higher risk of thyroid and kidney ...

This is the fifth post in a series on non-pharmacologic treatments of bipolar disorder. Previous posts briefly reviewed the evidence for amino acids, the B vitamin choline, and a proprietary nutrient ...

Lithium is safe and tolerable as maintenance therapy for up to 28 weeks for children and teens with bipolar disorder (BD), new research suggests. A randomized, double-blind study showed that ...

Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel ...

Changes Clinical Practice: Based on this large trial, lithium alone or a lithium-valproate combination should be used as first-line maintenance treatment for bipolar affective disorder type I instead ...

A new meta-analysis of six randomized controlled trials shows that lithium supplementation does not significantly slow cognitive decline in people with mild cognitive impairment or Alzheimer’s disease ...

Alzamend Neuro, Inc. (NASDAQ:ALZN) on Wednesday announced the completion of the clinical portion of its first Phase 2 ...

Seven years after breakout film role in Bradley Cooper‘s A Star Is Born, Lady Gaga recently recalled her challenging ...

Higher lithium serum levels linked to elevated rates of hypothyroidism, hyperthyroidism, and CKD3+. (HealthDay News) — Lithium is associated with an increased risk for thyroid dysfunction and chronic ...